Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer
Clinical trial NCT06305702 · COMPLETED
Trial details
- NCT number
- NCT06305702
- Sponsor
- Liaoning Cancer Hospital & Institute
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-01
- Primary completion
- 2023-12-31
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.